Thirty Madison Pricing Analysis & Total Cost: Is It Worth It?

What Is Thirty Madison and How Does Its Business Model Work?

Thirty Madison is a New York-based direct-to-consumer (D2C) telehealth holding company. It does not operate a single storefront. Instead, it runs condition-specific sub-brands: Keeps for androgenetic alopecia, Cove for migraine, Facet for skincare, and Evens for acid reflux and irritable bowel symptoms. Each sub-brand offers an asynchronous or synchronous online consultation, then ships medication directly to the patient.

The company charges a bundled subscription that folds the consultation, provider review, and drug dispensing into one recurring line item. That structure makes pricing opaque compared with visiting a physician separately and filling a prescription at a local pharmacy.

Revenue Model and Where Margins Come From

Thirty Madison earns margin at two points: the consultation fee and the drug markup. Because it operates its own pharmacy network, it captures dispensing revenue that would otherwise go to a retail chain. The FDA does not regulate drug pricing, so Thirty Madison sets its own rates independent of any public benchmark.

Patients who use GoodRx or Cost Plus Drugs for the same generic molecules can often pay substantially less, as shown in the cost comparison table later in this article.

Is Thirty Madison a Legitimate Medical Provider?

Yes, with important caveats. Thirty Madison's affiliated providers are licensed in the states where they practice, and the company's affiliated pharmacies are licensed by state boards. The drugs prescribed are FDA-approved for the claimed indications (finasteride for male-pattern hair loss, sumatriptan for acute migraine, tretinoin for acne). The FDA maintains a searchable database of approved drug products at accessdata.fda.gov confirming approval status for each active ingredient [1].

The caveats are business-model caveats, not safety caveats. Asynchronous telehealth lacks the in-person physical exam that some clinical guidelines recommend before prescribing. For finasteride specifically, the American Hair Loss Association notes that baseline PSA testing and prostate history are clinically relevant in older men [2].

Keeps Pricing: Hair Loss Treatment Costs Broken Down

Keeps offers finasteride 1 mg (oral), minoxidil 5% topical solution or foam, and oral minoxidil 2.5 mg. It also sells combination plans. The monthly cost depends on which product or bundle a patient selects.

Finasteride 1 mg Monthly Cost

Keeps charges approximately $22, $30 per month for finasteride 1 mg, billed quarterly. The GoodRx cash price for finasteride 1 mg (30-tablet supply) at major retail pharmacies is roughly $10, $15 per month as of early 2025 [3]. That gap, $7, $15 per month, represents the telehealth premium for asynchronous clinical review and home delivery.

Finasteride's efficacy is well established. The key Phase III trial published in the Journal of the American Academy of Dermatology (N=1,553 men) showed 5-year continuous finasteride use increased hair count by 277 hairs in a defined 1 cm² scalp area vs. A net loss of 100 hairs with placebo (P<0.001) [4]. The FDA approved finasteride 1 mg (Propecia) for androgenetic alopecia in men in 1997 [1].

Topical Minoxidil Cost

Keeps topical minoxidil 5% runs $20, $25 per month. Generic minoxidil 5% solution is available over the counter at pharmacies for $8, $12 per month without any prescription. The Keeps price includes pharmacist/provider oversight, but patients can self-select OTC minoxidil without a consultation under current FDA OTC labeling [5].

Oral Minoxidil Cost

Oral minoxidil 2.5 mg sits at $30, $35 per month through Keeps. This formulation is not FDA-approved specifically for hair loss; it is prescribed off-label from the approved antihypertensive indication. A systematic review in the Journal of the American Academy of Dermatology (2021, N=634 patients across 16 studies) found oral minoxidil at doses of 0.25 to 5 mg/day produced clinically meaningful hair regrowth in both men and women with limited cardiovascular adverse events at low doses [6]. GoodRx cash price for oral minoxidil 2.5 mg (30 tablets) is approximately $12, $18 per month [3].

Combination Plans and True Monthly Cost

Keeps bundles finasteride plus topical minoxidil for approximately $45, $55 per month. Purchasing both generics separately through GoodRx would cost roughly $18, $27 per month for the same molecules. The Keeps bundle therefore carries a 60 to 100% premium over cash-pay generics, though it includes ongoing provider messaging access.

Cove Pricing: Migraine Treatment Costs

Cove prescribes acute migraine treatments (triptans, NSAIDs) and preventive treatments (topiramate, propranolol, amitriptyline, and CGRP monoclonal antibodies including erenumab/Aimovig and fremanezumab/Ajovy).

Triptan Pricing

Sumatriptan 50 mg (9 tablets) through Cove runs approximately $30, $55 per month. The GoodRx cash price for generic sumatriptan 50 mg (9 tablets) is roughly $12, $20 [3]. Rizatriptan 10 mg (6 tablets) through Cove falls in a similar range.

The American Headache Society's 2021 evidence-based guideline states that triptans are Level A evidence for acute migraine treatment and remain first-line when OTC analgesics fail [7]. All triptans prescribed by Cove carry FDA approval for acute migraine [1].

Preventive Oral Medications

Topiramate 25 to 100 mg through Cove costs approximately $25, $40 per month. Generic topiramate at GoodRx runs $10, $18 per month [3]. The 2012 Cochrane review of topiramate for migraine prevention (N=1,455 across 17 trials) found 50 to 200 mg/day reduced migraine frequency by approximately 1.2 attacks per month vs. Placebo [8].

CGRP Biologics: The Most Expensive Tier

Erenumab (Aimovig) 70 mg monthly self-injection carries a list price above $700 per month without insurance. Cove negotiates manufacturer subsidies and coupon programs, advertising patient costs as low as $180, $220 per month for eligible patients. The STRIVE trial (N=955) showed erenumab 70 mg reduced monthly migraine days by 3.2 days vs. 1.8 days for placebo at 6 months (P<0.001) [9]. Patients with commercial insurance who obtain a neurologist referral may access Aimovig at $5 per month via Amgen's patient support program, making Cove's $180, $220 price relevant mainly for uninsured patients who cannot or will not engage traditional specialty care [10].

Facet and Evens Pricing

Facet (Skincare)

Facet prescribes tretinoin cream (0.025 to 0.1%), clindamycin-tretinoin gel, azelaic acid, and niacinamide. Subscription costs range from $35, $60 per month depending on the formulation. Generic tretinoin 0.05% cream (45 g tube) at GoodRx costs $15, $30 [3]. The FDA approved tretinoin cream for acne vulgaris in 1971; its efficacy at 12 weeks for reducing inflammatory lesions is documented in multiple vehicle-controlled trials [11].

Evens (GI Health)

Evens covers omeprazole (20 mg, 40 mg) and famotidine for GERD and acid reflux. Monthly cost through Evens is $20, $30. Both drugs are available OTC without a prescription. Omeprazole 20 mg (42 capsules) costs $9, $14 at most retail pharmacies OTC [3]. The Evens value proposition relies entirely on the provider consultation component, since the active drugs require no prescription.

Thirty Madison vs. Alternatives: Cost and Clinical Comparison

The table below summarizes how Thirty Madison sub-brands compare with direct-access pharmacy platforms and traditional care pathways for the same drug-indication pairs.

| Condition | Thirty Madison Sub-Brand | Monthly Cost | GoodRx Cash Price (Same Drug) | Traditional Care Pathway | |---|---|---|---|---| | Male AGA (finasteride 1 mg) | Keeps | $22, $30 | $10, $15 | $10, $15 Rx + $100, $200/yr MD visit | | AGA combo (fin + minox topical) | Keeps | $45, $55 | $18, $27 | $18, $27 Rx + provider visit | | Acute migraine (sumatriptan 50 mg x9) | Cove | $30, $55 | $12, $20 | $12, $20 Rx + neurology/PCP visit | | Migraine prevention (topiramate) | Cove | $25, $40 | $10, $18 | $10, $18 Rx + provider visit | | Acne (tretinoin 0.05%) | Facet | $35, $60 | $15, $30 | $15, $30 Rx + derm visit | | GERD (omeprazole 20 mg) | Evens | $20, $30 | $9, $14 OTC | OTC, no Rx needed |

The pattern is consistent: Thirty Madison charges a 40 to 120% premium over GoodRx cash prices for the same generic molecules. The premium funds asynchronous provider access, follow-up messaging, and home delivery. Whether that premium is "worth it" depends on a patient's access to in-person care, time cost, and comfort with asynchronous clinical encounters.

Ro (formerly Roman) and Hims & Hers operate nearly identical D2C telehealth business models. Hims charges approximately $25, $35 per month for finasteride [12], roughly comparable to Keeps. Ro's finasteride subscription runs approximately $23, $28 per month. For migraine, no major D2C competitor matches Cove's breadth of preventive options including CGRP biologics.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) is not a telehealth provider but offers prescription generics at cost-plus-15% margins. Finasteride 1 mg (90 tablets) is listed at approximately $6 for a 3-month supply, approximately $2/month, far below any D2C telehealth price [13]. Patients who already have a prescription from any provider can fill it there.

Clinical Efficacy of Drugs Thirty Madison Prescribes

The drugs Thirty Madison prescribes are not proprietary formulations. They are FDA-approved generics with decades of trial data. The company's value is in access and convenience, not in novel pharmacology.

Finasteride Efficacy Evidence

The 5-year PLESS trial extension and the Finasteride Male Pattern Hair Loss Study Group's controlled data (N=1,553) remain the foundational evidence. At year 1, 86% of finasteride-treated men maintained or increased their hair count vs. 42% in the placebo group [4]. The FDA label notes sexual adverse effects (decreased libido, erectile dysfunction) in 1.8% of treated men vs. 1.3% placebo, with resolution in most men after discontinuation [1].

Sumatriptan and Migraine Outcomes

A 2016 Cochrane review of sumatriptan 50 mg (N=12,339 patients across 22 trials) found 2-hour pain-free rates of 30% vs. 11% placebo (NNT = 5.3) [14]. These are the numbers a clinician should communicate before prescribing, and Cove's intake process addresses contraindications including cardiovascular risk via patient-reported screening.

CGRP Antagonist Evidence

The STRIVE trial for erenumab is one of several Phase III studies. The HALO CM trial for fremanezumab (N=1,130) showed 225 mg monthly reduced monthly migraine days by 4.3 vs. 2.5 for placebo over 12 weeks (P<0.001) [15]. These are meaningful reductions for patients with 8 or more migraine days per month, the population Cove targets for biologic therapy.

What Thirty Madison Does Not Cover: Clinical Gaps

Thirty Madison's asynchronous model has real limitations that affect both safety and clinical value.

No Lab Integration

Keeps does not order serum DHT, PSA, or hormonal panels before prescribing finasteride. The Endocrine Society's clinical practice guideline on male hypogonadism recommends baseline testosterone and PSA assessment in men over 40 before initiating 5-alpha reductase inhibitors [16]. Thirty Madison's intake is questionnaire-based, not lab-integrated.

No Physical Exam

Scalp photography submitted by the patient is the primary diagnostic input for Keeps. Dermatology guidelines from the American Academy of Dermatology recommend trichoscopy and, in ambiguous cases, scalp biopsy to rule out scarring alopecias before initiating finasteride [17]. A false-positive diagnosis of androgenetic alopecia in a patient with lichen planopilaris could delay appropriate treatment.

No Insurance Billing

None of Thirty Madison's sub-brands bills insurance. Patients with commercial insurance or Medicaid who see a PCP or dermatologist may obtain identical prescriptions at zero or low copay after their deductible. The Thirty Madison model is most cost-effective for the uninsured or under-insured patient who faces high specialist visit costs.

Who Pays Less With Thirty Madison and Who Pays More?

Patients who likely pay less (net) with Thirty Madison or a comparable D2C platform:

• Uninsured adults seeking finasteride or topical minoxidil for the first time, who would otherwise pay $150, $300 for a dermatology out-of-pocket visit.
• Patients in rural areas with 4 to 8 week waits for dermatology appointments.
• Adults whose employer insurance carries a $3,000+ individual deductible, making out-of-pocket specialist visits expensive.

Patients who likely pay more with Thirty Madison:

• Any insured patient with low copays who can see a PCP or dermatologist within 2 to 3 weeks.
• Patients who already have a valid prescription and can fill it at Cost Plus Drugs or use a GoodRx coupon.
• Men over 40 who need lab monitoring before finasteride, since Thirty Madison's price does not include blood work. Adding a lab draw through a third-party like LabCorp changes the effective cost comparison.

The American Academy of Family Physicians notes that telehealth platforms increase access for geographically isolated or cost-sensitive patients, but that in-person care remains the standard of care for complex or ambiguous presentations [18].

Is Thirty Madison Worth the Cost? A Clinical and Financial Verdict

The question resolves differently depending on what the patient already has. For a 28-year-old uninsured man with classic male-pattern hair loss who wants finasteride, Keeps at $22, $30/month represents reasonable value: he pays a telehealth premium for the convenience of skipping a $150, $250 out-of-pocket dermatology visit. For a 45-year-old man with insurance and a $30 dermatology copay, Keeps costs more than the traditional pathway when annualized.

For Cove migraine patients, the calculus is more complex. Sumatriptan via Cove costs more than GoodRx, but Cove's ability to prescribe CGRP biologics with subsidy navigation is genuinely useful for uninsured migraine patients who would otherwise struggle to access a neurologist. The CGRP biologics category is where Cove adds the most distinctive value relative to pharmacy-only alternatives.

Thirty Madison's pricing is legal, transparent in aggregate (though not always easy to parse on landing pages), and tied to FDA-approved drugs with solid trial evidence. The premium over generic cash-pay prices averages 40 to 100% across product lines. Whether that premium is justified depends on a patient's insurance status, geography, and baseline access to specialty care.

Patients considering Thirty Madison should compare the total annual cost (subscription x 12, plus any lab fees they add separately) against the cost of a single in-person visit plus a GoodRx prescription before enrolling.